Sebastian Krempien M.D.

Sebastian Krempien, MD, is a Board Certified Neurologist with extensive experience in clinical development spanning various phases from I to IV. Currently serving as Vice President of Clinical Development at Cybin Inc. since September 2022, Sebastian previously worked as a freelance consultant specializing in neuropharmaceutical clinical development and medical affairs from June 2017 to October 2022. Past roles include Medical Unit Leader for CNS at AbbVie and Senior Medical Advisor at Boehringer Ingelheim, with substantial expertise in interacting with regulatory agencies (EMA and FDA) and a focus on a range of CNS indications such as Multiple Sclerosis, Parkinson’s Disease, and Alzheimer’s Disease. Sebastian has a strong track record in both hands-on clinical experience and leadership within medical affairs teams across multiple organizations.